Summary & Overview
CPT 3018F: Specific Clinical Reporting Item
CPT code 3018F is a CPT-system billing descriptor for a specific clinical reporting or procedural item. Although the source description does not include a narrative summary, the code functions within the CPT framework used nationally to standardize reporting of medical services and procedures. The code's presence in the CPT lexicon makes it relevant for clinical documentation, claims submission, and quality reporting across payers.
Key payers addressed in this publication include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of the code's purpose as documented, the service context where available, and guidance on where to locate supplemental code guidance. The report outlines expected areas of interest for national stakeholders: clinical context and service type (when available), payer coverage patterns, benchmark and policy implications, and techniques for integrating the code into claims workflows.
This summary equips billing managers, compliance officers, and policy analysts with a clear starting point for understanding CPT code 3018F, identifying gaps in available documentation, and locating the next steps for payer-specific coverage and coding guidance.
Billing Code Overview
CPT code 3018F has no summary available in the source description. Based on the code listing, this entry represents a specific clinical reporting or procedural item within the CPT coding system. Service type: Data not available in the input. Typical site of service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an otolaryngology clinic with chronic nasal obstruction, recurrent sinus infections, or suspected sinonasal tumor requiring endoscopic evaluation and biopsy. The clinical workflow begins with history and nasal endoscopic exam in clinic. If targeted tissue sampling is needed, the patient is scheduled for an office-based or operating room endoscopic nasal procedure under local or general anesthesia. The team documents indication, informed consent, targeted anatomic site, and laterality. Peri-procedural steps include topical decongestant/vasoconstrictor application, endoscopic visualization, biopsy or excision of mucosal tissue or mass, hemostasis, and specimen submission to pathology. Post-procedure instructions address pain control, nasal care, activity restrictions, and follow-up for pathology review and further management.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician or other qualified health care professional on the same day of the procedure | Use when a distinct E/M visit is documented on the same date as the procedure. |
50 | Bilateral procedure | Use when the same procedure is performed on both sides during the same session.
| Distinct procedural service | Use to indicate a procedure or service that is distinct and separate from other services on the same day when not reported with anatomic modifiers.